Impaired blood flow to the pain region has been observed in persons with both chronic regional and widespread pain during various provocations, e.g., cold water, needle stimulation by acupuncture, and static or dynamic contractions (
Acero et al. 1999;
Larsson et al. 1999;
Sandberg et al. 2005;
Elvin et al. 2006;
Hallman et al. 2011); for comprehensive reviews on this topic see
Passatore and Roatta (2006) and
Vierck (2006).
In these pain conditions
, it has been argued that enhanced sympathetic activity may contribute to impaired blood flow and nociceptive muscle pain due to an imbalance between vasoconstriction and vasodilatation (
Passatore and Roatta 2006). When the oxygen demands are not adequately met, the muscles become ischemic and the local accumulation of metabolites may result in nociceptor activation, which, in turn, can enhance sympathetic outflow (
Passatore and Roatta 2006;
Vierck 2006). Hence,
excessive sympathetic activation may play an important role in generation of muscle pain by mediating the response to various kinds of physical and psychological stressors. Once pain has become chronic, additional effects on ANS regulation can also be expected. First, amplification of afferent nociceptive signals may activate the sympathetic system through somato-sympathetic reflexes (
Sato and Schmidt 1973); this occurs at a central level. This activation may result in further intensification of pain due to sensitization occurring at both the peripheral and central levels. Second, chronic pain is a strong psychological stressor that also activates the sympathetic system. As such, it seems possible that chronic pain can be maintained through a self-perpetuating (vicious) cycle.
Empirical support for this model is gained from studies examining widespread pain (fibromyalgia). Bengtsson and Bengtsson (1988) demonstrated that
blocking the sympathetic stellate ganglions relieved pain in fibromyalgia patients, and they hypothesized that this was due to improved microcirculation. More recently, it was found, in a randomized controlled trial, that injections of norepinephrine (noradrenalin) evoked pain in fibromyalgia patients (
Martinez-Lavin et al. 2002).
An alternative explanation for blunted blood flow response to stress in people with chronic muscle pain, proposed by
Maekawa et al. (2002), is
ß2-receptor down regulation due to prolonged sympathetic activation. This would also explain a blunted blood flow response to stress, owing to a lack of vasodilatation. Further experimental and clinical studies are needed to elucidate the possible relationships between sympathetic function, impaired blood flow regulation and nociceptive sensitization in pathogenesis of chronic muscle pain